Fulltext

HIV care models during the COVID-19 era

Guaraldi G 1 , Milic J 1 , Martinez E 2 , Kamarulzaman A 3 , Mussini C 1 , Waters L 4 Show all authors , Pozniak A 5 , Mallon P 6 , Rockstroh J 7 , Lazarus JV 8

Affiliations 

  • 1 Modena HIV Metabolic Clinic (MHMC). Department of Surgical, Medical, Dental and Morphological Sciences. University of Modena and Reggio Emilia. Italy
  • 2 Infectious Diseases Unit, Hospital Clínic and University of Barcelona, Barcelona, Spain
  • 3 Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 4 Mortimer Market Centre, Central & NW London NHS Trust, London, UK
  • 5 Chelsea and Westminster Hospital NHS Foundation Trust and LSHTM, London, UK
  • 6 University College Dublin Centre for Experimental Pathogen Host Research, Dublin, Ireland
  • 7 Department of Medicine I, Bonn University Hospital, Bonn, Germany
  • 8 Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain
Clin Infect Dis, 2020 Dec 19.
PMID: 33340037 DOI: 10.1093/cid/ciaa1864

Abstract

The COVID-19 pandemic is an unprecedented global challenge that substantially risks reversing the progress in ending HIV. At the same time, it may offer the opportunity for a new era of HIV management. This viewpoint presents the impact of COVID-19 on HIV care, including the Joint United Nations Programme on HIV/AIDS (UNAIDS) "three 90s" targets. It outlines how to enhance a patient-centered care approach, now known as the "fourth 90," by integrating face-to-face patient-physician and telemedicine encounters. It suggests a framework for prevention and treatment of multimorbidity and frailty, to achieve a good health-related quality of life and preserve intrinsic capacity in all people living with HIV.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications